Emerging Therapies for PBC, NASH and ESLD and HCC Seminar Series 2020 from Feb 01, 2020 07:30 AM to Oct 17, 2020 03:40 PMVarious Dates and Locations - See Below,
As the prevalence and severity of liver disease increases in the United States, largely due to chronic viral hepatitis and fatty liver disease, the need for education and training programs among physicians and mid-level providers has escalated. With on-going research and new pharmacological agents being tested, the SC Liver Research Consortium is uniquely positioned to bring cutting-edge information to the medical community. With a focus on Non-Alcohol Stetohepatitis (NASH), Primary Biliary Cholangitis (PBC) and Hepatocellular Carcinoma (HCC) a series of one-day, interactive seminars will be offered in 12 cities. Faculty for this innovative program will be comprised of clinical and research experts who practice locally. The faculty team is comprised for two physicians and one nurse practitioner or physician assistant who will provide a team-based approach to diagnosis, treatment and patient care.
Viral Hepatitis Update and Training Seminar series: August 1 - December 5, 2020 from Aug 01, 2020 07:30 PM to Dec 05, 2020 04:30 PMVarious Dates and Locations - See Below,
This seminar series will provide updates on the diagnosis and treatment of the two dominant forms of viral hepatitis (Hepatitis B and C) and explore the resurgence of Hepatitis A and the future impact of Delta Hepatitis and Hepatitis E. Location-specific faculty experts will deliver state-of-the-art material in a setting that stresses interaction with the participants. The Viral Hepatitis Training and Treatment Update will increase the number of clinicians educated on the causes of chronic viral hepatitis, as well as best practices to preventing, diagnosing, treating, and/or referring patients to liver specialists.
Treating Irritable Bowel Syndrome and Chronic Idiopathic Constipation For Primary Care Clinicians: September 16, 2020 - March 10, 2021 from Sep 16, 2020 06:30 AM to Mar 10, 2021 08:45 AMVarious Dates and Locations - See Below,
This activity will provide physicians and mid-level providers a good foundation of the symptoms, diagnostic approaches and treatment therapies for chronic idiopathic constipation patients with irritable bowel syndrome with IBS-D (diarrhea), IBS-C (constipation) and CIC. Special emphasis will be placed on the exploration of newly approved agents into clinical practice. Key topics to be discussed include the diagnosis of IBS, the safety and efficacy of recently approved pharmacologic agents, and optimizing treatment and patient management approaches.